We are live on ! Find out more
APC

Aspire Private Capital Portfolio holdings

AUM $484M
1-Year Est. Return 17.28%
This Fund
S&P 500
This Quarter Est. Return
-11.1%
1 Year Est. Return
+17.28%
3 Year Est. Return
+49.56%
5 Year Est. Return
+43.58%
10 Year Est. Return
AUM
$280M
AUM Growth
-$33.2M
Cap. Flow
+$4.21M
Cap. Flow %
1.5%
Top 10 Hldgs %
44.79%
Holding
682
New
40
Increased
132
Reduced
127
Closed
15
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GMDA
651
DELISTED
Gamida Cell Ltd. Ordinary Shares
GMDA
$0 ﹤0.01%
+200
New +$508
BCEL
652
DELISTED
Atreca, Inc. Class A Common Stock
BCEL
$0 ﹤0.01%
200
BTTX
653
DELISTED
Better Therapeutics, Inc. Common Stock
BTTX
$0 ﹤0.01%
+200
New +$335
NEPT
654
DELISTED
Neptune Wellness Solutions Inc. Ordinary Shares
NEPT
0
SRC
655
DELISTED
SPIRIT REALTY CAPITAL, INC.
SRC
$0 ﹤0.01%
+1
New +$42
EQRXW
656
DELISTED
EQRx, Inc. Warrant
EQRXW
$0 ﹤0.01%
40
FATH.WS
657
DELISTED
Fathom Digital Manufacturing Corporation Warrants, each whole warrant exercisable for one Class A Common Stock at an exercise price of $11.50 per share
FATH.WS
$0 ﹤0.01%
50
HYLD
658
DELISTED
High Yield ETF
HYLD
$0 ﹤0.01%
6
APGN
659
DELISTED
Apexigen, Inc. Common Stock
APGN
$0 ﹤0.01%
100
-100
-50% -$1.01K
APGNW
660
DELISTED
Apexigen, Inc. WarrantApexigen, Inc. Warrant
APGNW
-100
Closed
CPUH.WS
661
DELISTED
Compute Health Acquisition Corp. Redeemable warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50
CPUH.WS
$0 ﹤0.01%
50
CPUH
662
DELISTED
Compute Health Acquisition Corp.
CPUH
-200
Closed -$2K
HEXO
663
DELISTED
HEXO Corp. Common Shares
HEXO
$0 ﹤0.01%
9
RAMMW
664
DELISTED
Aries I Acquisition Corporation
RAMMW
$0 ﹤0.01%
50
CUEN
665
DELISTED
Cuentas Inc. Common Stock
CUEN
$0 ﹤0.01%
23
VLDR
666
DELISTED
Velodyne Lidar, Inc. Common Stock
VLDR
$0 ﹤0.01%
195
SVFAW
667
DELISTED
SVF Investment Corp. Warrant
SVFAW
$0 ﹤0.01%
60
EPHYW
668
DELISTED
Epiphany Technology Acquisition Corp. Warrant
EPHYW
$0 ﹤0.01%
100
EPHY
669
DELISTED
Epiphany Technology Acquisition Corp. Class A Common Stock
EPHY
-300
Closed -$3K
COLIW
670
DELISTED
Colicity Inc. Warrant
COLIW
$0 ﹤0.01%
40
COLI
671
DELISTED
Colicity Inc. Class A Common Stock
COLI
-200
Closed -$2K
REVH
672
DELISTED
Revolution Healthcare Acquisition Corp. SAIL Class A Common Stock
REVH
-100
Closed -$1K
REVHW
673
DELISTED
Revolution Healthcare Acquisition Corp. SAIL Warrant.
REVHW
$0 ﹤0.01%
20
NDACW
674
DELISTED
NightDragon Acquisition Corp. Warrants to purchase Class A common stock
NDACW
$0 ﹤0.01%
40
NDAC
675
DELISTED
NightDragon Acquisition Corp. Class A Common stock
NDAC
-200
Closed -$2K

Similar funds

Aspire Private Capital's Q2 2022 Portfolio in Review

As of Q2 2022, Aspire Private Capital held 682 positions worth $280M, down 11% from $313M the previous quarter. Its ten largest holdings account for 45% of the portfolio.

Aspire Private Capital's Q2 2022 filing shows 40 new, 132 increased, 127 reduced and 15 closed positions. Its largest new stake was State Street SPDR Portfolio Intermediate Term Treasury ETF: 57,406 shares worth $1.69M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $5.36M.

By sector, the portfolio is most concentrated in Technology at 3.9% of assets, down from 4.3% a quarter earlier, followed by Industrials and Healthcare.

  • Aspire Private Capital's largest Q2 2022 buy was State Street SPDR Portfolio Intermediate Term Treasury ETF: 57,406 shares worth $1.69M.
  • Aspire Private Capital added most to State Street Fixed Income Sector Rotation ETF in Q2 2022, an estimated $4.62M increase.
  • Aspire Private Capital's biggest Q2 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $5.36M.
  • Aspire Private Capital fully exited iShares Russell Top 200 Growth ETF in Q2 2022, selling an estimated $139K.
  • Aspire Private Capital's ten largest holdings make up 45% of its $280M portfolio in Q2 2022.
  • Aspire Private Capital opened 40 new positions and closed 15 in Q2 2022.
  • Aspire Private Capital's portfolio value fell 11% quarter-over-quarter to $280M.

Based on Aspire Private Capital's 13F filing for Q2 2022, filed 1 Aug 2022.